-
221
-
222
Cardiovascular disease risk in cancer survivors: a population-based cohort study from the UK Biobank, and meta-analysis of cohort studies
Published 2025-01-01“…Introduction In addition to the well-recognised cardiotoxicity of cancer treatment, possible aetiological links between cancer diagnosis and cardiovascular disease (CVD) have gained growing research interests. …”
Get full text
Article -
223
Evaluation of the effectiveness of the Iran-package of essential non-communicable disease (IraPEN) program in reducing cardiovascular disease risk in pilot areas
Published 2025-02-01Subjects: “…Cardiovascular disease…”
Get full text
Article -
224
-
225
Dose-response risks of all-cause, cancer, and cardiovascular disease mortality according to sex-specific cigarette smoking pack-year quantiles
Published 2024-07-01“…Introduction This study investigated the risks for all-cause death and death from cancer or cardiovascular diseases due to smoking status and behavior, focusing on differences in smoking duration and amount stratified by sex. …”
Get full text
Article -
226
-
227
-
228
Cost of primary care approaches for hypertension management and risk-based cardiovascular disease prevention in Bangladesh: a HEARTS costing tool application
Published 2022-06-01“…Objective To estimate the costs of scaling up the HEARTS pilot project for hypertension management and risk-based cardiovascular disease (CVD) prevention at the full population level in the four subdistricts (upazilas) in Bangladesh.Settings Two intervention scenarios in subdistrict health complexes: hypertension management only, and risk-based integrated hypertension, diabetes, and cholesterol management.Design Data obtained during July–August 2020 from subdistrict health complexes on the cost of medications, diagnostic materials, staff salaries and other programme components.Methods Programme costs were assessed using the HEARTS costing tool, an Excel-based instrument to collect, track and evaluate the incremental annual costs of implementing the HEARTS programme from the health system perspective.Primary and secondary outcome measures Programme cost, provider time.Results The total annual cost for the hypertension control programme was estimated at US$3.2 million, equivalent to US$2.8 per capita or US$8.9 per eligible patient. …”
Get full text
Article -
229
-
230
Association between social determinants of health and premature atherosclerotic cardiovascular disease and sex differences in US adults: A cross-sectional study
Published 2025-02-01Subjects: “…Atherosclerotic cardiovascular disease…”
Get full text
Article -
231
-
232
Potential impact of coronaviruses upon cardiovascular system under COVID-19 pandemic
Published 2020-06-01Subjects: “…cardiovascular diseases…”
Get full text
Article -
233
-
234
Early Prediction of Cardio Vascular Disease (CVD) from Diabetic Retinopathy using improvised deep Belief Network (I-DBN) with Optimum feature selection technique
Published 2025-01-01Subjects: “…Cardiovascular disease…”
Get full text
Article -
235
-
236
Dyslipidaemia in patients with chronic kidney disease – a neglected cardiovascular risk factor
Published 2023-11-01Subjects: Get full text
Article -
237
The association between short-term apparent temperature exposure and human coagulation: A time-series study from Beijing, 2014–2023
Published 2025-01-01Subjects: Get full text
Article -
238
Vascularization, Innervation, and Inflammation: Pathways Connecting the Heart–Brain Axis and Implications in a Clinical Setting
Published 2025-01-01Subjects: Get full text
Article -
239
-
240
Beyond LDL cholesterol: remnant cholesterol is associated with cardiometabolic risk factors in children
Published 2025-01-01Subjects: “…Cardiovascular disease…”
Get full text
Article